A fully integrated, R&D-driven biotechnology company listed on the Hong Kong Stock Exchange (1672.HK). ... biotech entity) and Shaoxing ...
News
- 1 in 4 ABC patients treated with Novartis Kisqali remain progression-free beyond 4 years
- AI-Powered Deep Proteomics Enables Early, Non-Imaging Detection of Breast Cancer With ...
At the San Antonio Breast Cancer Symposium (SABCS) in San Antonio ... Bioscience's Certitude Breast test, a breakthrough, AI-powered proteomics ...
- CellRight Technologies, LLC Announces Update and Senior Leadership Changes
CellRight announces Senior leadership changes, implementation of new commercial plan and cost reduction initiatives. SAN ANTONIO, TX / ACCESS ...
- Biomea Fusion Announces KOL Presentation and Interview on Menin and Icovamenib at ...
... San Antonio. The interview highlights the growing body of preclinical ... astr<60 is a webinar series created by astr partners for biotech and finance ...
- BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025
... San Antonio Breast Cancer Symposium taking place December 9-12, 2025 at ... When it comes to biotech ETFs, they give sector participants exposure to ...